Detalles de la búsqueda
1.
Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients' subgroups.
J Autoimmun
; 125: 102744, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34781162
2.
Systemic sclerosis Progression INvestiGation (SPRING) Italian registry: demographic and clinico-serological features of the scleroderma spectrum.
Clin Exp Rheumatol
; 38 Suppl 125(3): 40-47, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32301427
3.
Practice pattern for the use of intravenous iloprost for the treatment of peripheral vasculopathy in systemic sclerosis: A case-control study from the Italian national multicenter "SPRING" (Systemic Sclerosis Progression InvestiGation) Registry.
J Scleroderma Relat Disord
; 9(1): 38-49, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38333531
4.
Retention and clinical response to abatacept in patients with rheumatoid arthritis: an Italian perspective.
Clin Exp Rheumatol
; 36(5): 935-936, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29600933
5.
Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phase.
J Transl Autoimmun
; 7: 100212, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37854035
6.
Early Spondyloarthritis Clinic: Organizational Improvements in the Patient Journey.
Front Med (Lausanne)
; 9: 833139, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35685409
7.
Implementing a simple pharmacovigilance program to improve reporting of adverse events associated with biologic therapy in rheumatology: Preliminary results from the Calabria Biologics Pharmacovigilance Program (CBPP).
PLoS One
; 13(10): e0205134, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30356301
Resultados
1 -
7
de 7
1
Próxima >
>>